
    
      Primary Objective

      To compare the prevalence of ototoxicity and neurotoxicity in GCT cancer survivors who only
      had surgery to a similar population from The Platinum Study (RSRB45410/1305011509) who
      received cisplatin-based combination chemotherapy.

      Secondary Objective

      To compare the prevalence of obesity, hypertension, and use of antidepressants/anxiolytics in
      GCT cancer survivors who only had surgery to a similar population from The Platinum Study who
      received cisplatin-based combination chemotherapy.
    
  